Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma

2012228 citationsJournal Articlebronze Open Access

Authors

Vikrant V. Sahasrabuddhe · Department of Health and Human Services

Munira Z. Gunja · National Cancer Institute

Barry I. Graubard · National Cancer Institute

Britton Trabert · National Cancer Institute

Lauren M. Schwartz · National Institutes of Health

Yikyung Park · National Cancer Institute

Albert R. Hollenbeck

Abstract

Aspirin use was associated with reduced risk of developing HCC and of death due to CLD whereas nonaspirin NSAID use was only associated with reduced risk of death due to CLD.

Topics & Keywords

Liver Disease Diagnosis and Treatment Cancer, Lipids, and Metabolism Hepatocellular Carcinoma Treatment and Prognosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JNCI Journal of the National Cancer Institute

Volume 104, Issue 23, pp. 1808-1814

DOI: 10.1093/jnci/djs452

Field-Weighted Citation Impact: 10.87